Imaging-derived biomarkers from 68Ga-DOTATOC PET/CT scans to predict survival of patients with neuroendocrine tumors after PRRT with 177Lu-DOTATATE

Imaging-derived biomarkers from 68Ga-DOTATOC PET/CT scans to predict survival of patients with neuroendocrine tumors after PRRT with 177Lu-DOTATATE

Abstract Background Neuroendocrine tumors have increased in prevalence and diversity in recent years and are often diagnosed at metastatic stages. Compared with nonradioactive systemic treatment with somatostatin analogs, peptide receptor radionuclide therapy (PRRT) has shown superior overall surviv...

Full description

Saved in:
Bibliographic Details
Main Authors: Stephan Raad, Ali Al-Fatlawi, C. Louise Wise, Christian Fottner, Simin Schadmand-Fischer, Mathias Schreckenberger, Matthias M. Weber, Thomas J. Musholt, Michael Schroeder, Matthias Miederer
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Cancer Imaging
Subjects:
Neuroendocrine tumors
PRRT
68Ga-DOTATOC PET/CT
Tumor volume
SUV
Radiomics
Online Access:https://doi.org/10.1186/s40644-025-00899-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40644-025-00899-5

Similar Items